Evidence map›Paper›PMID 37090719›Full record

ArticleFrontiers in immunology2023

Metagenomic insights into the composition and function of the gut microbiota of mice infected with

Jin-Xin Meng, Xin-Yu Wei, Huanping Guo, Yu Chen, Wei Wang, Hong-Li Geng, Xing Yang, Jiang Jiang, Xiao-Xuan Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. AcuteMicroorganisms · 2025
    Article
  7. Life (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Metagenomic analysis of gut microbiota composition and function in wild mice (Frontiers in cellular and infection microbiology · 2025
    Article
  10. Article
  11. Toxoplasma-induced behavior changes - is microbial dysbiosis the missing link?Frontiers in cellular and infection microbiology · 2024
    Review
  12. Therapeutic potential ofBrain communications · 2024
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Jin-Xin MengCollege of Veterinary Medicine, Qingdao Agricultural University, Qingdao, Shandong, China.
Xin-Yu WeiCollege of Life Science, Changchun Sci-Tech University, Changchun, China.
Huanping GuoState Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, Heilongjiang, China.
Yu ChenCollege of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, Heilongjiang, China.
Wei WangCollege of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, Heilongjiang, China.
Hong-Li GengCollege of Veterinary Medicine, Qingdao Agricultural University, Qingdao, Shandong, China.
Xing YangDepartment of Medical Microbiology and Immunology, School of Basic Medicine, Dali University, Dali, Yunnan, China.
Jiang JiangCollege of Life Science, Changchun Sci-Tech University, Changchun, China.
Xiao-Xuan ZhangCollege of Veterinary Medicine, Qingdao Agricultural University, Qingdao, Shandong, China.
Heilongjiang Bayi Agricultural University · CNQingdao Agricultural University · CNChangchun University · CNDali University · CNHarbin Veterinary Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Despite Toxoplasma gondii infection leading to dysbiosis and enteritis, the function of gut microbiota in toxoplasmosis has not been explored. Methods: Here, shotgun metagenomics was employed to characterize the composition and function of mouse microbial community during acute and chronic T. gondii infection, respectively. Results: The results revealed that the diversity of gut bacteria was decreased immediately after T. gondii infection, and was increased with the duration of infection. In addition, T. gondii infection led to gut microbiota dysbiosis both in acute and chronic infection periods. Therein, several signatures, including depression of Firmicutes to Bacteroidetes ratio and infection-enriched Proteobacteria, were observed in the chronic period, which may contribute to aggravated gut inflammation and disease severity. Functional analysis showed that a large amount of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and carbohydrate-active enzymes (CAZy) family displayed distinct variation in abundance between infected and healthy mice. The lipopolysaccharide biosynthesis related pathways were activated in the chronic infection period, which might lead to immune system imbalance and involve in intestinal inflammation. Moreover, microbial and functional spectrums were more disordered in chronic than acute infection periods, thus implying gut microbiota was more likely to participate in disease process in the chronically infected mice, even exacerbated immunologic derangement and disease progression. Discussion: Our data indicate that the gut microbiota plays a potentially important role in protecting mice from T. gondii infection, and contributes to better understand the association between gut microbiota and toxoplasmosis.

Indexed as

Gastrointestinal MicrobiomeToxoplasmaToxoplasmosisAnimalsDysbiosisInflammationMicePersistent Infectiongut microbiotaintestinal inflammationmetagenomic sequencingToxoplasma gondiitoxoplasmosis

Identifiers

PMID37090719
PMCPMC10118048
OpenAlexW4362672840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.